Literature DB >> 27379837

Traumatic brain injury decreases AMP-activated protein kinase activity and pharmacological enhancement of its activity improves cognitive outcome.

Julia L Hill1, Nobuhide Kobori1, Jing Zhao1, Natalia S Rozas1, Michael J Hylin1, Anthony N Moore1, Pramod K Dash2.   

Abstract

Prolonged metabolic suppression in the brain is a well-characterized secondary pathology of both experimental and clinical traumatic brain injury (TBI). AMP-activated kinase (AMPK) acts as a cellular energy sensor that, when activated, regulates various metabolic and catabolic pathways to decrease ATP consumption and increase ATP synthesis. As energy availability after TBI is suppressed, we questioned if increasing AMPK activity after TBI would improve cognitive outcome. TBI was delivered using the electromagnetic controlled cortical impact model on male Sprague-Dawley rats (275-300 g) and C57BL/6 mice (20-25 g). AMPK activity within the injured parietal cortex and ipsilateral hippocampus was inferred by western blots using phospho-specific antibodies. The consequences of acute manipulation of AMPK signaling on cognitive function were assessed using the Morris water maze task. We found that AMPK activity is decreased as a result of injury, as indicated by reduced AMPK phosphorylation and corresponding changes in the phosphorylation of its downstream targets: ribosomal protein S6 and Akt Substrate of 160 kDa (AS160). Increasing AMPK activity after injury using the drugs 5-amino-1-β-d-ribofuranosyl-imidazole-4-carboxamide or metformin did not affect spatial learning, but significantly improved spatial memory. Taken together, our results suggest that decreased AMPK activity after TBI may contribute to the cellular energy crisis in the injured brain, and that AMPK activators may have therapeutic utility. Increased phosphorylation of Thr172 activates AMP-activated protein kinase (AMPK) under conditions of low cellular energy availability. This leads to inhibition of energy consuming, while activating energy generating, processes. Hill et al., present data to indicate that TBI decreases Thr172 phosphorylation and that its stimulation by pharmacological agents offers neuroprotection and improves memory. These results suggest that decreased AMPK phosphorylation after TBI incorrectly signals the injured brain that excess energy is available, thereby contributing to the cellular energy crisis and memory impairments.
© 2016 International Society for Neurochemistry.

Entities:  

Keywords:  glucose metabolism; hippocampus; memory retention; traumatic brain injury

Mesh:

Substances:

Year:  2016        PMID: 27379837      PMCID: PMC5037010          DOI: 10.1111/jnc.13726

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  73 in total

1.  Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain.

Authors:  M R Owen; E Doran; A P Halestrap
Journal:  Biochem J       Date:  2000-06-15       Impact factor: 3.857

2.  Metabolic crisis without brain ischemia is common after traumatic brain injury: a combined microdialysis and positron emission tomography study.

Authors:  Paul Vespa; Marvin Bergsneider; Nayoa Hattori; Hsiao-Ming Wu; Sung-Cheng Huang; Neil A Martin; Thomas C Glenn; David L McArthur; David A Hovda
Journal:  J Cereb Blood Flow Metab       Date:  2005-06       Impact factor: 6.200

3.  Diffuse prolonged depression of cerebral oxidative metabolism following concussive brain injury in the rat: a cytochrome oxidase histochemistry study.

Authors:  D A Hovda; A Yoshino; T Kawamata; Y Katayama; D P Becker
Journal:  Brain Res       Date:  1991-12-13       Impact factor: 3.252

4.  The effect of cyclosporine A on the phosphorylation of the AMPK pathway in the rat hippocampus.

Authors:  Hong Geun Park; Heesun Yi; Se Hyun Kim; Hyun Sook Yu; Yong Min Ahn; Young Han Lee; Myoung-Sun Roh; Yong Sik Kim
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2011-09-22       Impact factor: 5.067

Review 5.  Metformin: from mechanisms of action to therapies.

Authors:  Marc Foretz; Bruno Guigas; Luc Bertrand; Michael Pollak; Benoit Viollet
Journal:  Cell Metab       Date:  2014-10-30       Impact factor: 27.287

6.  Pre-treatment with metformin activates Nrf2 antioxidant pathways and inhibits inflammatory responses through induction of AMPK after transient global cerebral ischemia.

Authors:  Ghorbangol Ashabi; Leila Khalaj; Fariba Khodagholi; Mahdi Goudarzvand; Alireza Sarkaki
Journal:  Metab Brain Dis       Date:  2014-11-21       Impact factor: 3.584

7.  Selective death of newborn neurons in hippocampal dentate gyrus following moderate experimental traumatic brain injury.

Authors:  Xiang Gao; Ying Deng-Bryant; Wongil Cho; Kimberly M Carrico; Edward D Hall; Jinhui Chen
Journal:  J Neurosci Res       Date:  2008-08-01       Impact factor: 4.164

Review 8.  AMPK: An Energy-Sensing Pathway with Multiple Inputs and Outputs.

Authors:  D Grahame Hardie; Bethany E Schaffer; Anne Brunet
Journal:  Trends Cell Biol       Date:  2015-11-23       Impact factor: 20.808

9.  A HPLC method for simultaneous determination of 5-aminoimidazole-4-carboxamide riboside and its active metabolite 5-aminoimidazole-4-carboxamide ribotide in tumor-bearing nude mice plasma and its application to pharmacokinetics study.

Authors:  Xiaoliang Cheng; Liping Guo; Zaiquan Li; Liang Li; Tianyan Zhou; Wei Lu
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2013-01-04       Impact factor: 3.205

10.  Structure of mammalian AMPK and its regulation by ADP.

Authors:  Bing Xiao; Matthew J Sanders; Elizabeth Underwood; Richard Heath; Faith V Mayer; David Carmena; Chun Jing; Philip A Walker; John F Eccleston; Lesley F Haire; Peter Saiu; Steven A Howell; Rein Aasland; Stephen R Martin; David Carling; Steven J Gamblin
Journal:  Nature       Date:  2011-03-13       Impact factor: 49.962

View more
  14 in total

1.  7,8-Dihydroxyflavone facilitates the action exercise to restore plasticity and functionality: Implications for early brain trauma recovery.

Authors:  Gokul Krishna; Rahul Agrawal; Yumei Zhuang; Zhe Ying; Afshin Paydar; Neil G Harris; Luiz Fernando F Royes; Fernando Gomez-Pinilla
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-03-14       Impact factor: 5.187

2.  mTOR/AMPK signaling in the brain: Cell metabolism, proteostasis and survival.

Authors:  Carla Garza-Lombó; Annika Schroder; Elsa M Reyes-Reyes; Rodrigo Franco
Journal:  Curr Opin Toxicol       Date:  2018-05-17

3.  Tackling Neuroinflammation After Traumatic Brain Injury: Complement Inhibition as a Therapy for Secondary Injury.

Authors:  Inge A M van Erp; Iliana Michailidou; Thomas A van Essen; Mathieu van der Jagt; Wouter Moojen; Wilco C Peul; Frank Baas; Kees Fluiter
Journal:  Neurotherapeutics       Date:  2022-10-12       Impact factor: 6.088

4.  (-)-Epigallocatechin-3-gallate provides neuroprotection via AMPK activation against traumatic brain injury in a mouse model.

Authors:  Yinyin Wu; Jing Cui
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-02-15       Impact factor: 3.000

5.  Neuroprotective effects of metformin on traumatic brain injury in rats is associated with the AMP-activated protein kinase signaling pathway.

Authors:  Siavash Rahimi; Ahmadreza Ferdowsi; Ali Siahposht-Khachaki
Journal:  Metab Brain Dis       Date:  2020-07-03       Impact factor: 3.584

6.  α7-Acetylcholine Receptor Signaling Reduces Neuroinflammation After Subarachnoid Hemorrhage in Mice.

Authors:  Ari Dienel; Remya A Veettil; Kanako Matsumura; Jude P J Savarraj; H Alex Choi; Peeyush Kumar T; Jaroslaw Aronowski; Pramod Dash; Spiros L Blackburn; Devin W McBride
Journal:  Neurotherapeutics       Date:  2021-05-10       Impact factor: 6.088

7.  Neurological Enhancement Effects of Melatonin against Brain Injury-Induced Oxidative Stress, Neuroinflammation, and Neurodegeneration via AMPK/CREB Signaling.

Authors:  Shafiq Ur Rehman; Muhammad Ikram; Najeeb Ullah; Sayed Ibrar Alam; Hyun Young Park; Haroon Badshah; Kyonghwan Choe; Myeong Ok Kim
Journal:  Cells       Date:  2019-07-21       Impact factor: 6.600

8.  AMPK induces regulatory innate lymphoid cells after traumatic brain injury.

Authors:  Babak Baban; Molly Braun; Hesam Khodadadi; Ayobami Ward; Katelyn Alverson; Aneeq Malik; Khoi Nguyen; Skon Nazarian; David C Hess; Scott Forseen; Alexander F Post; Fernando L Vale; John R Vender; Md Nasrul Hoda; Omid Akbari; Kumar Vaibhav; Krishnan M Dhandapani
Journal:  JCI Insight       Date:  2021-01-11

Review 9.  Mini Review of Controlled Cortical Impact: A Well-Suited Device for Concussion Research.

Authors:  Nicole Osier; C Edward Dixon
Journal:  Brain Sci       Date:  2017-07-20

10.  Metformin Use Associated with Reduced Risk of Dementia in Patients with Diabetes: A Systematic Review and Meta-Analysis.

Authors:  Jared M Campbell; Matthew D Stephenson; Barbora de Courten; Ian Chapman; Susan M Bellman; Edoardo Aromataris
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.